LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Drug-induced radiation recall reactions and non-anticancer drugs: A descriptive analysis from VigiBase®.

Aubin-Beale, Eyrian / Giorgi, Lorene / Beurrier, Mathilde / Granel-Brocard, Florence / Gillet, Pierre / Fresse, Audrey

Fundamental & clinical pharmacology

2023  Volume 37, Issue 3, Page(s) 673–679

Abstract: Radiation recall reactions are inflammatory reactions confined to previously irradiated tissues, often of drug-induced etiology, particularly with anticancer therapies. Other drugs, in particular COVID-19 vaccines, may also be involved. To describe ... ...

Abstract Radiation recall reactions are inflammatory reactions confined to previously irradiated tissues, often of drug-induced etiology, particularly with anticancer therapies. Other drugs, in particular COVID-19 vaccines, may also be involved. To describe radiation recall reactions under non-anticancer drugs more precisely, we extracted the cases of radiation recall reactions associated with non-anticancer drugs from WHO pharmacovigilance database VigiBase®. We performed two analyses from this extraction: a global analysis and an analysis focusing on vaccination-related issues. We extracted 120 cases corresponding to 269 drugs, of which 130 were non-anticancer (22 vaccines). Among the non-anticancer drugs, tozinameran was the most reported treatment (4.46% of cases), followed by levofloxacin (2.97%) and folinic acid (2.60%), dexamethasone (2.23), and ChAdOx1 nCoV-19 vaccine and prednisone (1.86% each). Among vaccines, tozinameran (54.55% of cases) was the most reported, followed by ChAdOx1 nCoV-19 (22.73%), HPV and inactivated influenza vaccine (9.09% each), and elasomeran (4.55%). Our study first describes the occurrence of radiation recall reactions during non-anticancer treatment. It also highlights a potential safety signal with COVID-19 vaccines.
MeSH term(s) Humans ; COVID-19 Vaccines ; ChAdOx1 nCoV-19 ; COVID-19/epidemiology ; COVID-19/prevention & control ; BNT162 Vaccine ; Radiodermatitis ; Influenza Vaccines
Chemical Substances COVID-19 Vaccines ; ChAdOx1 nCoV-19 (B5S3K2V0G8) ; BNT162 Vaccine ; Influenza Vaccines
Language English
Publishing date 2023-01-11
Publishing country England
Document type Journal Article
ZDB-ID 639134-5
ISSN 1472-8206 ; 0767-3981
ISSN (online) 1472-8206
ISSN 0767-3981
DOI 10.1111/fcp.12866
Shelf mark
Zs.A 2247: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top